The National Security Commission on Emerging Biotechnology (NSCEB) is a bipartisan U.S. legislative commission established in March 2022 by section 1091 of the National Defense Authorization Act for Fiscal Year 2022. The Commission was directed to examine the national security implications of emerging biotechnologies, including their relevance to the Department of Defense, and to provide recommendations to Congress and the executive branch.